No abstract available
MeSH terms
-
Adolescent
-
Adult
-
Antineoplastic Agents / administration & dosage*
-
Antineoplastic Agents / therapeutic use
-
Child
-
Disease-Free Survival
-
Doxorubicin / administration & dosage
-
Doxorubicin / therapeutic use
-
Humans
-
Ifosfamide / administration & dosage
-
Ifosfamide / therapeutic use
-
Neoplasm Metastasis
-
Osteosarcoma / drug therapy
-
Osteosarcoma / mortality
-
Osteosarcoma / pathology
-
Randomized Controlled Trials as Topic
-
Sarcoma / drug therapy*
-
Sarcoma / mortality
-
Sarcoma / pathology
-
Sirolimus / administration & dosage
-
Sirolimus / analogs & derivatives
-
Sirolimus / therapeutic use
-
TOR Serine-Threonine Kinases / antagonists & inhibitors
Substances
-
Antineoplastic Agents
-
ridaforolimus
-
Doxorubicin
-
MTOR protein, human
-
TOR Serine-Threonine Kinases
-
Ifosfamide
-
Sirolimus